SanBio Company Limited (TYO:4592)
Japan flag Japan · Delayed Price · Currency is JPY
952.00
-19.00 (-1.96%)
Aug 6, 2026, 10:45 AM JST

SanBio Company Financials Overview

Millions JPY. Fiscal year is Feb - Jan.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-3,740-3,794-3,516-4,539-7,899-6,620
Net Income
-3,147-3,842-2,882-2,644-5,559-4,677
Earnings Per Share
-42.11-52.55-41.85-40.48-95.98-90.31
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Cash & Investments
13,99815,0832,9214,4546,7324,557
Total Debt
1,1801,2383976659332,524
Net Cash (Debt)
12,81813,8452,5243,7895,7992,033
Net Cash Growth
490.42%448.53%-33.39%-34.66%185.24%-76.03%
Net Cash Per Share
164.21189.3536.6558.00100.1239.26

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Operating Cash Flow
--3,760-3,603-4,765-7,434-6,546
Capital Expenditures
--32-4-11-7-42
Free Cash Flow
--3,792-3,607-4,776-7,441-6,588
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingApr '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
PS Ratio
------